What do we need to do to tackle antimicrobial resistance?

The Lancet Global Health

Volumn 2, Issue 1, 2014, Pages

  Fears, Robin ^a   ter Meulen, Volker ^b  

^a German National Academy of Sciences Leopoldina   (Germany)

^b InterAcademy Panel   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ECONOMIC ASPECT; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH EDUCATION; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; INFECTION; LETTER; MEDICINE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; DRUG UTILIZATION; HEALTH;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; GLOBAL HEALTH; HUMANS;

EID: 84890856436     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(13)70086-X     Document Type: Letter

References (11)

1. Antibiotic resistance threats in the United States CDC, Atlanta: US Centers for Disease Control and Prevention, 2013. (accessed Oct 16, 2013). http://www.cdc.gov/drugresistance/threat-report-2013.
2. Annual epidemiological report 2012: reporting on 2010 surveillance data and 2011 epidemic intelligence data 2012, ECDC, European Centre for Disease Prevention and Control, Stockholm, (accessed Oct 16, 2013). http://www.ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf.
3. The evolving threat of antimicrobial resistance: options for action 2012, WHO, World Health Organization, Geneva, (accessed Oct 16, 2013). http://whqlibdoc.who.int/publications/2012/9789241503181_eng.pdf.
4. Antimicrobial resistance (factsheet no 194) 2013, WHO, World Health Organization, Geneva, (accessed Oct 16, 2013). http://www.who.int/mediacentre/factsheets/fs194/en.
5. Ghafur A, Mathai D, Muruganathan A, et al. The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer 2013, 50:71-73.
6. European public health and innovation policy for infectious disease: the view from EASAC 2011, EASAC, European Academies Science Advisory Council, Halle (Saale), (accessed Oct 16, 2013). http://www.easac.eu/fileadmin/PDF_s/reports_statements/EASAC%20Infectious%20Disease%20report%20web%20document.pdf.
7. Drug resistance in infectious agents-a global threat to humanity. G-Science Academies G-Science Academies, (accessed Oct 21, 2013). http://www.leopoldina.org/uploads/tx_leopublication/2013_G8_Statement_Drug_Resistance_to_Infectious_Agents_01.pdf.
8. Antimicrobial resistance-a call for action 2013, IAP-IAMP, InterAcademy Panel, InterAcademy Medical Panel, Trieste, (accessed Nov 18, 2013). http://www.interacademies.net/IAP_IAMP_Nov2013.aspx.
9. A new global partnership: eradicate poverty and transform economies through sustainable development 2013, High-level panel of eminent persons on the post-2015 development agenda, United Nations, New York, (accessed July 19, 2013). http://www.post2015hlp.org/wp-content/uploads/2013/05/UN-Report.pdf.
10. Response to the report of the high level panel of eminent persons on the post-2015 development agenda-"a new global partnership" 2013, IAP, InterAcademy Panel, Trieste, (accessed Oct 16, 2013). http://www.interacademies.net/File.aspx?id=22364.
11. Meulen V, Hassan M, Fears R Global networks: InterAcademy Panel to inform policy. Nature 2013, 498:434.